We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.02B
AUM Growth
+$513M
Cap. Flow
+$460M
Cap. Flow %
22.74%
Top 10 Hldgs %
21.5%
Holding
481
New
197
Increased
58
Reduced
57
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 7.95%
2 Industrials 7.82%
3 Consumer Discretionary 5.99%
4 Communication Services 5.9%
5 Consumer Staples 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYV icon
251
Live Nation Entertainment
LYV
$42.1B
$954K 0.05%
+31,400
New +$899K
EQIX icon
252
Equinix
EQIX
$102B
$941K 0.05%
+2,350
New +$892K
CF icon
253
CF Industries
CF
$18.9B
$927K 0.05%
+31,600
New +$1.03M
UTI icon
254
Universal Technical Institute
UTI
$2.15B
$903K 0.04%
261,853
-24,020
-8% -$81.2K
DBD
255
DELISTED
Diebold Nixdorf Incorporated
DBD
$896K 0.04%
+29,200
New +$825K
KITE
256
DELISTED
Kite Pharma, Inc.
KITE
$879K 0.04%
+11,200
New +$693K
OVV icon
257
Ovintiv
OVV
$16.4B
$877K 0.04%
+14,980
New +$898K
INCY icon
258
PUT
Incyte
INCY
$26B
$869K 0.04%
+6,500
New +$828K
M icon
259
Macy's
M
$6.62B
$851K 0.04%
28,700
+7,700
+37% +$238K
VMC icon
260
Vulcan Materials
VMC
$37.4B
$849K 0.04%
+7,050
New +$862K
CLVS
261
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
$828K 0.04%
+13,000
New +$790K
HZNP
262
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$828K 0.04%
56,000
-126,000
-69% -$2.04M
TXMD icon
263
TherapeuticsMD
TXMD
$23.8M
$807K 0.04%
2,242
-10,825
-83% -$3.35M
MOS icon
264
The Mosaic Company
MOS
$7.34B
$797K 0.04%
27,300
+20,200
+285% +$624K
JD icon
265
PUT
JD.com
JD
$42.9B
$778K 0.04%
+25,000
New +$736K
ALKS icon
266
CALL
Alkermes
ALKS
$8.42B
$761K 0.04%
+13,000
New +$737K
GILD icon
267
Gilead Sciences
GILD
$167B
$734K 0.04%
+10,800
New +$759K
RXDX
268
DELISTED
Ignyta, Inc.
RXDX
$688K 0.03%
+80,000
New +$585K
VNCE icon
269
Vince Holding Corp
VNCE
$77.6M
$674K 0.03%
43,475
+13,475
+45% +$323K
SAGE
270
DELISTED
Sage Therapeutics
SAGE
$661K 0.03%
9,300
-11,900
-56% -$697K
POT
271
DELISTED
Potash Corp Of Saskatchewan
POT
$646K 0.03%
37,800
+9,200
+32% +$167K
ZDGE icon
272
Zedge
ZDGE
$38.4M
$617K 0.03%
200,904
SPG icon
273
PUT
Simon Property Group
SPG
$76.8B
$602K 0.03%
+3,500
New +$625K
XLF icon
274
CALL
State Street Financial Select Sector SPDR ETF
XLF
$57.4B
$593K 0.03%
+25,000
New +$599K
QCP
275
DELISTED
Quality Care Properties, Inc.
QCP
$572K 0.03%
30,334
-48,200
-61% -$857K

Similar funds

J. Goldman & Co's Q1 2017 Portfolio in Review

As of Q1 2017, J. Goldman & Co held 481 positions worth $2.02B, up 34% from $1.51B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

J. Goldman & Co deployed $460M of net new capital in Q1 2017, opening 197 new positions and adding to 58 existing holdings. Its largest new stake was Time Warner Inc: 345,000 shares worth $33.7M.

By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 6.7% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was CSX Corp, an estimated $13.1M trimmed.

  • J. Goldman & Co's largest Q1 2017 buy was Time Warner Inc: 345,000 shares worth $33.7M.
  • J. Goldman & Co added most to NXP Semiconductors in Q1 2017, an estimated $17.2M increase.
  • J. Goldman & Co's biggest Q1 2017 reduction was CSX Corp, cutting an estimated $13.1M.
  • J. Goldman & Co fully exited Bath & Body Works in Q1 2017, selling an estimated $27.4M.
  • J. Goldman & Co's ten largest holdings make up 22% of its $2.02B portfolio in Q1 2017.
  • J. Goldman & Co opened 197 new positions and closed 164 in Q1 2017.
  • J. Goldman & Co's portfolio value rose 34% quarter-over-quarter to $2.02B.

Based on J. Goldman & Co's 13F filing for Q1 2017, filed 15 May 2017.